TG Therapeutics Inc (TGTX)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 179,894 | 92,933 | 102,304 | 298,887 | 553,439 |
| Short-term investments | US$ in thousands | 131,106 | 124,575 | 59,374 | 15,876 | 51,987 |
| Receivables | US$ in thousands | 129,185 | 51,093 | 0 | 1,389 | — |
| Total current liabilities | US$ in thousands | 90,679 | 53,720 | 53,201 | 65,384 | 87,554 |
| Quick ratio | 4.85 | 5.00 | 3.04 | 4.84 | 6.91 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($179,894K
+ $131,106K
+ $129,185K)
÷ $90,679K
= 4.85
The quick ratio of TG Therapeutics Inc, which measures the company's ability to cover its short-term liabilities with its most liquid assets, has shown a steady decline over the years. As of December 31, 2020, the quick ratio was strong at 6.91, indicating a healthy liquidity position. However, by December 31, 2022, the quick ratio had decreased to 3.04, reflecting a potential decrease in the company's ability to meet its short-term obligations without relying on slower-moving inventory.
Although there was a slight improvement in the quick ratio by December 31, 2023, reaching 5.00, it still remained below the initial level in 2020. The trend continued as of December 31, 2024, with a quick ratio of 4.85. This suggests that TG Therapeutics Inc may need to carefully manage its liquidity position and ensure it has sufficient liquid assets to cover its short-term liabilities in the future.
Peer comparison
Dec 31, 2024